Thank you, Lisa, and thanks for joining us. The biopharmaceutical and Diagnostic Solutions segment delivered another solid ...

The drugs have names that sound like small planets: semaglutide, liraglutide, lixisenatide. Collectively, they belong to a class of glucagon-like peptide 1 (GLP-1) analogs that has reshaped the ...

Cardlytics, Inc. (NASDAQ:CDLX) Q4 2025 Earnings Call Transcript March 4, 2026 Cardlytics, Inc. misses on earnings ...

Good morning, everybody. My name is Kyahn Williamson, SVP of Investor Relations and Corporate Communications at Telix. And we're very pleased to welcome you today to our investor call and webcast to ...

TD Cowen 46th Annual Health Care Conference March 2, 2026 10:30 AM ESTCompany ParticipantsSujal Patel - Co-Founder, ...

The fourth quarter reflected the strengths and challenges facing Portillo's Inc. in 2025. While our core markets continue to ...

Claude Cowork lets AI analyze files, browse the web, and run business tasks autonomously. Allie K. Miller explains exactly ...

This transcript has been lightly edited for clarity. The interview took place Feb. 19, 2026.

Bilibili Inc. (NASDAQ:BILI) Q4 2025 Earnings Call Transcript March 5, 2026 Bilibili Inc. beats earnings expectations. Reported EPS is $0.2773, expectations were $0.27. Operator: Good day, and welcome ...

Good afternoon, and thank you for joining us for BioLife Solutions, Inc.'s fourth quarter and full year 2025 conference call.

Christina Majaski writes and edits finance, credit cards, and travel content. She has 14+ years of experience with print and digital publications. Lea Uradu, J.D., is a Maryland state registered tax ...

Nautilus was founded to address a long-standing challenge in life sciences, the lack of technologies capable of ...